• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Clin Pract . Development and application of a new framework for infectious disease management at early stage of new epidemics: taking COVID-1

tetano

Editor, Senior Moderator
Int J Clin Pract


. 2021 Mar 24;e14174.
doi: 10.1111/ijcp.14174. Online ahead of print.
Development and application of a new framework for infectious disease management at early stage of new epidemics: taking COVID-19 outbreak in China as an example


Ziyi Li[SUP] 1 [/SUP], Cheng Li[SUP] 2 [/SUP], Xinyin Wu[SUP] 3 [/SUP], Guanming Li[SUP] 1 [/SUP], Guowei Li[SUP] 1 4 [/SUP], Junzhang Tian[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The outbreak of coronavirus disease 2019 (COVID-19) rapidly spread across worldwide, posing a significant challenge to the public health. Several shortcomings in the existing infectious disease management system were exposed during the pandemic, which hindered the control of the disease globally. To cope with this issue, we propose a window-period framework to reveal the general rule of the progression of management of infectious diseases, and to help with decision-making at early stage of epidemics with a focus on healthcare provisions.
Methods: The framework has two significant periods (dark-window period and bright-window period). Outbreak of COVID-19 in China was used as an example for the application of the framework.
Results: The framework could reflect the progression of the epidemic objectively. The spread increased slowly in the dark-window period, but rocketed up in the bright-window period. The beginning of bright-window period was the time when healthcare personnel were exposed to a substantially high risk of nosocomial infection. Additionally, proper and prompt preventive actions during the dark-window and bright-window period were substantially important to reduce the future spreading of the disease.
Conclusions: It was recommended that when possible healthcare provisions should upgrade to the highest level of alert for the control of an unknown epidemic in the dark-window period, while countermeasures in the bright-window period could be accordingly adjusted with full exploration and considerations. The framework may provide some insights into how to accelerate the control of future epidemics in a prompt and effective fashion.

Keywords: COVID-19; SARS-CoV-2; emerging infectious disease; infectious disease management; nosocomial infection.
 
Back
Top Bottom